TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 115 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $392,000 | -43.6% | 3,387 | -51.9% | 0.00% | -100.0% |
| Q1 2018 | $695,000 | -49.3% | 7,043 | -46.2% | 0.00% | 0.0% |
| Q4 2017 | $1,370,000 | -7.1% | 13,084 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,474,000 | +0.5% | 13,084 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,466,000 | -7.6% | 13,084 | -3.8% | 0.00% | 0.0% |
| Q1 2017 | $1,587,000 | +51.4% | 13,606 | +36.6% | 0.00% | +100.0% |
| Q4 2016 | $1,048,000 | +112.6% | 9,957 | +123.1% | 0.00% | 0.0% |
| Q3 2016 | $493,000 | -30.3% | 4,463 | -8.1% | 0.00% | 0.0% |
| Q2 2016 | $707,000 | +22.5% | 4,854 | +20.5% | 0.00% | 0.0% |
| Q1 2016 | $577,000 | – | 4,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |